Dexanabinol
Dexanabinol, also known under the designations HU-211 or ETS210, is a synthetic derivative of cannabinoids. Distinct from the majority of cannabinoid derivatives, Dexanabinol represents the "unnatural" enantiomer of the influential cannabinoid agonist HU-210. Its unique properties set it apart from the conventional effects observed with many cannabinoid compounds.
Pharmacological Action[edit | edit source]
Unlike most cannabinoids, HU-211 doesn't function as a cannabinoid receptor agonist. Instead, it exerts its effects primarily as an NMDA antagonist. As such, it doesn't mimic the typical cannabis-induced outcomes.
Neuroprotective and Anticonvulsant Properties[edit | edit source]
Dexanabinol demonstrates significant anticonvulsant and neuroprotective properties. These characteristics make it an area of keen interest in scientific research, especially in studies focusing on neural health and protection.
Therapeutic Potential[edit | edit source]
The unique properties of Dexanabinol make it a candidate for various therapeutic applications:
- Brain Injury or Stroke: Given its neuroprotective characteristics, Dexanabinol is being studied for its potential in treating conditions like brain injuries or strokes, where neural protection is crucial.
- Cancer Treatment: Preliminary research indicates potential applications of Dexanabinol in the treatment of certain types of cancers, particularly brain cancer.
- Anticonvulsant: Its anticonvulsant properties are also being explored for applications in conditions like epilepsy or other seizure-related disorders.
Clinical Trials[edit | edit source]
Dexanabinol has successfully passed the safety checks in clinical trials. It's currently undergoing Phase I trials, primarily focusing on its effectiveness and applicability in the treatment of brain cancer.
Mechanism of Action[edit | edit source]
Dexanabinol’s primary mechanism doesn't revolve around the cannabinoid receptors. Instead, its action as an NMDA antagonist has intrigued researchers, leading to multiple studies on its potential benefits.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD